Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.695 | 0.385 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.700 | None | 0.968 | 0 | 0 | 1981 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.900 | None | 0.971 | 0 | 0 | 1982 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.600 | None | 0.919 | 0 | 0 | 1986 | 2016 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.950 | 0 | 0 | 1987 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.600 | None | 0.972 | 0 | 0 | 1987 | 2020 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.962 | 0 | 0 | 1989 | 2020 | ||||||||
|
fibroblast growth factor 3 | 0.505 | 0.808 | 9.3E-05 |
|
disease | 0.600 | None | 0.968 | 0 | 0 | 1989 | 2015 | ||||||||
|
fibroblast growth factor 4 | 0.588 | 0.577 | 0.14 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 1989 | 2011 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.700 | None | 0.955 | 0 | 0 | 1992 | 2020 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.400 | None | 0.909 | 0 | 0 | 1992 | 2019 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.977 | 0 | 0 | 1994 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.700 | None | 0.950 | 0 | 0 | 1994 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1995 | 2019 | ||||||||
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.600 | None | 0.965 | 0 | 0 | 1996 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase kinase 13 | 0.743 | 0.192 | 0.80 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 1997 | 2017 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.700 | None | 0.966 | 0 | 0 | 1997 | 2020 | ||||||||
|
mitogen-activated protein kinase kinase 4 | 0.559 | 0.692 | 1.00 |
|
disease | 0.360 | None | 1.000 | 0 | 0 | 1998 | 2019 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 1998 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.700 | None | 0.992 | 0 | 0 | 1999 | 2020 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.400 | None | 0.940 | 0 | 0 | 1999 | 2020 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.700 | None | 0.952 | 0 | 0 | 2001 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.992 | 0 | 0 | 2001 | 2020 |